Wastewater surveillance of rotavirus, norovirus, and hepatitis a virus in the Middle East and North Africa Region: a systematic review Authors: Mariam Mroweh, Laura Hergelian, Bassel Serrieh, Aya Youssef, Maria Santana-Garces, Kyle Crooker, Marcus Zervos, Paul Kilgore, Nada M. Melhem Published: 2025 ABSTRACT BackgroundWastewater surveillance (WWS) is a valuable tool for monitoring circulating and emerging pathogens, and emerging variants, providing an early warning system for potential epidemics. Its use for key viral diarrheal pathogens like Rotavirus (RV), Norovirus (NoV), and Hepatitis A Virus (HAV) remains underexplored in the Middle East and North African (MENA) region. This systematic review aims to advance available data on the use of wastewater to monitor RV, NoV and HAV in countries of the MENA region.MethodsA systematic search of six databases (PubMed, Medline, EMBASE, Scopus, Cochrane, and Web of science) was conducted for studies published between 2014 and 2024 in the MENA region following PRISMA guidelines. Eligible studies reported on the use of wastewater to detect RV, NoV, and HAV. Articles on unrelated pathogens, wastewater treatment efficiency, or insufficient sampling data were excluded. Risk of bias assessment was conducted.ResultsWe retrieved 11 studies meeting our predefined inclusion criteria and were used to extract full data. These studies were from Egypt, Tunisia, Bahrain, and Jordan. RV was the most studied virus (64%), followed by HAV (45%) and NoV (18%). Most studies (73%) had a moderate risk of bias. All studies sampled wastewater treatment plants. The sampling period, frequency, and sample size varied substantially between studies. Positivity rates for RV, NoV, and HAV showed high variability, ranging between no detection and 100%. The predominantly reported genotypes were GI and P[8] for RV, GI for NoV, and IA for HAV.ConclusionThis review reveals significant gaps in WWS coverage across the MENA region for RV, NoV, and HAV, highlighting the need for investing in and expanding the use of WWS in the region. Effective surveillance of these viruses is pivotal to better understand the burden of these diseases and guide national public health interventions in the MENA region.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12889-025-26045-1. Introduction Wastewater surveillance (WWS), also known as wastewater-based epidemiology (WBE), serves as an environmental surveillance approach facilitating real-time monitoring of circulating pathogens and emerging variants; acting as an early warning system for potential epidemic threats. Wastewater (WW) harbors viral particles shed in the stool of infected individuals; thus, continuous and systematic monitoring of the former supports better understanding of dynamics of diseases in a community [1, 2]. WWS serves as a valuable tool to complement clinical surveillance, offering several advantages over the latter; including scalability, lower cost, and the ability to bypass certain biases inherent to clinical surveillance, such as the frequency of testing, symptomatic illness, medical-seeking behavior and access to healthcare [3, 4]. WWS played a critical role in the Global Polio Eradication Initiative (GPEI), implemented to monitor the risk of emergence and reemergence of polio [5, 6]. The combined efforts of clinical testing and WWS have significantly enhanced the sensitivity of the poliovirus surveillance system, contributing to the success of elimination of wild poliovirus in previously endemic countries [5, 7, 8]. The significant use of WWS was further expanded during and following the COVID-19 pandemic. Non-infective SARS-CoV-2 RNA fragments are shed in stool of infected individuals four days prior to the onset of symptoms [9]. WWS has been used to track SARS-CoV-2 variants, to identify emergent strains, and as an early warning system for potential hotspots while complementing routine surveillance strategies [4]. Many countries in Africa, the Americas, Europe, Southeast Asia, and the Western Pacific Region implemented national WWS systems as a monitoring tool for SARS-CoV-2 [10–12]. These environmental surveillance systems have been critical in guiding public health decisions, evaluating public health measures as well as anticipating surges of healthcare services [4, 13]. All of the above advance the significance of WWS in guiding efficient and timely public health responses as well as management of circulating pathogens in the community [4, 14]. Rotavirus (RV), Norovirus (NoV), and Hepatitis A Virus (HAV) or their non-infective RNA fragments are excreted in the stool of infected individuals throughout the course of infection [15]. Viral shedding of RV begins approximately two days prior to the onset of diarrhea and continues for several days post-onset of symptoms in healthy individuals [16]. In immunocompromised individuals, shedding of RV can persist for over 30 days post-infection [16]. NoV is shed in stool for an average of 6.9 days, where it can be detected for up to three weeks in 25% of cases in the stool of healthy individuals; whereas, immunosuppressed individuals exhibit prolonged shedding, lasting for more than four weeks [17, 18]. HAV is shed 10–12 days post-infection and continues for up to three weeks after the onset of symptoms [19]. Recent studies have demonstrated the detection of these viruses in WW prior to the emergence of symptomatic cases, with reported detection windows of 2–3 weeks, 5–13 weeks, and 2–4 weeks for RV, NoV and HAV, respectively [20–23]. According to the recently published Global Burden of Diseases (GBD 2021), diarrheal diseases accounted for 1.17 million deaths, recording a 5% decrease compared to the GBD 2019 [24], while incurring a substantial economic burden in low-income countries (LICs), middle-income countries (MICs) as well as high-income countries (HICs) [25–28]. Despite the availability and use of two RV vaccines, RV was the leading cause of diarrheal deaths in 2021 accounting for 15.2% of the deaths (176,000 estimated deaths with 120,000 deaths among children under the age of 5 years) [24]. NoV ranked second and accounted for 10.6% (124 000 estimated deaths) [24], with its GII genotype accounting for 32,870 global diarrheal deaths in children younger than five years old [29]. While many vaccine trials are in the pipeline, and despite the considerable progress that has been recently made [30, 31], to date we do not have an approved vaccine to prevent NoV-associated diarrhea [32]. The genetic diversity of the virus, and insufficient understanding of the natural immunity against it, have contributed to the delay in advancing a NoV vaccine [32–35]. A vaccine against HAV is currently in use [36], yet, the GBD 2021 [37] estimated an increase in HAV global acute infections compared to the GBD estimates of 2019 [38], accounting for 161 million and 159 million infections, respectively. However, the number of global deaths due to HAV estimated in 2021 (26,900 deaths) showed a decrease compared to those reported in 2019 (39,000 deaths) [37, 38]. Importantly, the burden of HAV infections was reported to be unevenly distributed worldwide; LICs and MICs contributed to 66% and 97% of the global acute HAV infections and deaths in 2019, respectively [38]. The use of WWS as an epidemiological tool for monitoring the circulation of NoV, RV and HAV has been documented [39–41]. A positive correlation has been established between the presence of these viruses in WW and clinical positivity rates, emphasizing the ability of WWS to predict dynamics of disease at the population level [39, 42–44]. This highlights the significance of using WW in monitoring and evaluating the burden of these viruses, offering insights into their circulation, and supporting public health interventions [20, 45]. RV, NoV and HAV exert a substantial burden in the Middle East and North Africa (MENA) region. Recent GBD data estimated 16,000 diarrheal deaths in the MENA region, of which 11,470 were in children under five years of age [24]; yet, accurate numbers and attributions based on causative agents are lacking in the region [46–49]. The Global Enteric Multicenter Study (GEMS) and Etiology, Risk factors, and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health (MAL-ED) models estimated global deaths due to diarrhea at 443,833 among children under 5 years [29]. Of these deaths, 12.5% (55,720 deaths) occurred in the Eastern Mediterranean region (EMR), of which RV accounted for 31.4% (17,470 deaths) and NoV accounted for 5.3% (2,950 deaths) [29]. The implementation of a WWS system in the MENA region to monitor the circulation trends of RV, NoV and HAV would support understanding the dynamics and transmission of these viruses as well as managing their burden. To our knowledge, there are no systematic reviews on the use of wastewater-based surveillance of these viruses in the region. Therefore, the aim of this systematic review is to advance a comprehensive review on the use of WW to monitor the circulation of RV, NoV and HAV in the region, the methods used as well as detected variants, and propose recommendations addressing knowledge gaps. Methods Search strategy and selection criteria A comprehensive systematic literature search was conducted for articles reporting on wastewater-based surveillance of viral pathogens, specifically RV, NoV and HAV, in countries of the MENA region between 2014 and 2024. The MENA countries included are Algeria, Bahrain, Djibouti, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Palestine, Qatar, Saudi Arabia, Sudan, Syria, Tunisia, UAE, and Yemen. These countries were included based on the classification of the World Bank and UNICEF. This systematic review was conducted following the Cochrane Handbook for Systematic Reviews of Interventions [50]. Our findings were reported in accordance with the 2020 Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement [51]. The search strategies were developed using the proper Medical Subject Headings (MESH) terms and keywords related to WWS and the countries mentioned above (“Wastewater,” “Waste Water,” “Sewage,” “Wastewater-Based Epidemiological Monitoring,” “Sewage-Based Surveillance,” “Wastewater Based Surveillance,” and “Norovirus”, “Rotavirus”, “Hepatitis A virus”). The terms were combined using “AND” and “OR” when applicable. The search was performed using six electronic bibliographic databases: PubMed, Medline, EMBASE, Scopus, Cochrane, and Web of science. To rule out potential source of bias to the selected studies and in order to account for unpublished and hard to reach material, the grey literature (through ProQuest and DANS EASY Archive) and the official sites of the public health ministries of each country were screened. The Global Health Library (GHL) was used to retrieve studies published on the regional databases namely: Index Medicus for the Eastern Mediterranean Region (IMEMR) and African Index Medicus (AIM). All search results were sent to the citation manager Endnote (version X8) where duplicates were removed. Studies conducted in any of the MENA countries listed above and using WWS for the detection of RV, NoV and HAV were included. Two independent reviewers (BS and AY) assessed the titles and abstracts of the exported studies retrieved by the search. Case studies and articles that did not have an English abstract were excluded. Disagreements were resolved by consensus of a third reviewer (LH). Articles that did not match our search keywords, did not clearly specify the detection of RV, NoV or HAV, conducted WWS on unrelated pathogens, focused on wastewater treatment efficiency, testing of treated WW samples, or reported incoherent data and insufficient sampling data were excluded. Study eligibility was further assessed by reading the full text taking into account all the former exclusion criteria. Data extraction Based on the pre-defined inclusion and exclusion criteria, the full-texts of potentially eligible or relevant titles and abstracts were screened using a standardized data sheet. Three reviewers (BS, MM, and LH) extracted the data independently from eligible studies and assessed the inclusion and exclusion criteria in detail. Studies reporting on treated WW, or advancing incoherent information, and had sampling periods of less than one month were excluded [52–55]. The abstracted information was checked by a fourth reviewer (NMM). The following information was extracted from each study when available: country, first author and year of publication, investigated viruses, duration of sampling, sampling frequency, detection methods, number of wastewater treatment plants tested, number of samples, positivity rates, and predominant genogroups or genotypes. When the studies did not report the positivity rate of any of the viruses of interest, the former was calculated based on the sample size and number of positive samples when data allowed. Risk of bias assessment We assessed the quality of the included studies by using and modifying the risk of bias assessment tool for prevalence studies developed by Hoy et al. [56]. The latter includes external validity controls, including representativeness of the target population at the national level, sampling frame representativeness, implementation of random selection and sample size calculation. Additionally, the tool contains internal validity controls, which encompass the validity of detection assays used, data collection modes, and length of study period (> 1 year). The risk of bias was classified as low (score of 7–9), moderate (score of 4–6) or high risk (score of 0–3). Two reviewers (MM and LH) independently assessed each article; a consensus was reached by a third reviewer (NMM). The results and criteria of this evaluation are presented in Table S1. Results Study selection The original search retrieved 126 articles related to WWS of RV, NoV and HAV in the MENA region. Based on our inclusion criteria, and after the removal of duplicate records (2 articles), 66 articles were eligible for title and abstract screening, and yielded 15 full-text articles for detailed assessment. Of these, four studies [52–55] were excluded due to insufficient sampling periods (less than one month), incoherent or incomplete data reporting, and a focus on treated wastewater rather than raw samples (Fig. 1). Accordingly, 11 studies met the inclusion criteria for detailed analysis. RV was reported in 64% of the studies (7/11), followed by HAV in 45% (5/11) and NoV in 18% (2/11). These studies were conducted in four countries: Egypt, Tunisia, Bahrain, and Jordan (Table 1); leaving the majority of MENA countries without any documented WWS data on RV, NoV, or HAV. Fig. 1Flow diagram of wastewater surveillance study selection in MENA countries (2014–2024) Flow diagram of wastewater surveillance study selection in MENA countries (2014–2024) Table 1Number of published studies in countries of the MENA region between 2014 and 2024CountryNumber of studiesViruses investigated (number of studies)Bahrain1Rotavirus, Hepatitis A VirusEgypt6Rotavirus A (2)Rotavirus C (1)Rotavirus A & C (1)Rotavirus, Hepatitis A Virus (1)Hepatitis A Virus (1)Jordan1Hepatitis A Virus, NorovirusTunisia3Rotavirus A (1)Hepatitis A Virus (1)Norovirus (1) Table 1Number of published studies in countries of the MENA region between 2014 and 2024CountryNumber of studiesViruses investigated (number of studies)Bahrain1Rotavirus, Hepatitis A VirusEgypt6Rotavirus A (2)Rotavirus C (1)Rotavirus A & C (1)Rotavirus, Hepatitis A Virus (1)Hepatitis A Virus (1)Jordan1Hepatitis A Virus, NorovirusTunisia3Rotavirus A (1)Hepatitis A Virus (1)Norovirus (1) Number of published studies in countries of the MENA region between 2014 and 2024 Characteristics of selected studies Studies conducted in countries of the MENA region primarily tested samples from wastewater treatment plants (WWTPs), focusing on both inlet (raw) and outlet (treated) WW in nine out of the 11 studies. In this review, we report only on raw sewage data (Table 2). Sampling periods varied widely and ranged between 4 and 37 months, with collection frequency as follows: weekly (two studies), monthly (two studies), and twice or thrice a month (one study). Similarly, the number of collected samples varied with a range of 3 to 259 (3–79 for HAV; 3-259 for NoV and 16–259 for RV). Five studies did not explicitly report on their sampling frequency, reflecting inconsistencies in study designs and reporting practices. These variations suggest differences in study objectives, resource availability, and logistical capacities. Table 2Wastewater surveillance data of rotavirus, norovirus and hepatitis A in the MENA region (2014-2024)CountryAuthor, Year of PublicationViruses StudiedDuration of Sampling (Months)Sampling FrequencyDetection MethodsNumber of WWTP SampledNumber of SamplesPositivity Rate (%)Predominant Genogroups or GenotypesEgyptEl-Senousy et al., 2015[57]RVA, RVC24MonthlyRT-PCR12416.7% (RVA); 8.3% (RVC)G1P[8]Hamza et al., 2017[58]HAV12NRRT-PCR33479.4%IBShaheen et al., 2019[59]RVC12Twice or thrice/monthSemi-nested RT-PCR13221.9%NREl-Senousy et al., 2020[60]RVA12*NRNested RT-PCR224100%G1 and P[4]Elmahdy el al., 2020[61]RVA12NRRT-PCR1NA†NANRAbd-Elshafy et al., 2022[62]RV, HAV8WeeklyRT-qPCR1219.5% (RV); 14.3% (HAV)NRTunisiaHassine- Zaafrane et al., 2014[63]NoV37Once a weekRT-PCR225938.6%GIBéji-Hamza et al., 2014[64]HAV24MonthlyNested RT-PCR37968.3%IAHassine-Zaafrane et al., 2015[65]RVA37Once a weekRT-qPCR225976.1%G1 and P[8]BahrainJanahi et al., 2020[66]RV, HAV4‡NRRT-PCR116§12.5% (RV); 12.5% (HAV)NRJordanSaadoun et al., 2021[67]HAV, NoV11NRNested RT-PCR (HAV); RT-PCR (NoV)13NDNRAbbreviations: HAV Hepatitis A virus, NoV Norovirus, RV Rotavirus, RVA Rotavirus A, RVC Rotavirus C, RT-PCR Reverse-Transcriptase Polymerase Chain Reaction, WWTP Wastewater Treatment Plant, ND Not Detected, NR Not Reported, NA Not Available*Two separate sampling periods divided into 6 months each†Exact numbers for raw sewage included in our study was not reported.‡2 separate sampling periods divided into 2 months each§Refers to raw and treated sewage, no distinction for number of raw sewage samples only Table 2Wastewater surveillance data of rotavirus, norovirus and hepatitis A in the MENA region (2014-2024)CountryAuthor, Year of PublicationViruses StudiedDuration of Sampling (Months)Sampling FrequencyDetection MethodsNumber of WWTP SampledNumber of SamplesPositivity Rate (%)Predominant Genogroups or GenotypesEgyptEl-Senousy et al., 2015[57]RVA, RVC24MonthlyRT-PCR12416.7% (RVA); 8.3% (RVC)G1P[8]Hamza et al., 2017[58]HAV12NRRT-PCR33479.4%IBShaheen et al., 2019[59]RVC12Twice or thrice/monthSemi-nested RT-PCR13221.9%NREl-Senousy et al., 2020[60]RVA12*NRNested RT-PCR224100%G1 and P[4]Elmahdy el al., 2020[61]RVA12NRRT-PCR1NA†NANRAbd-Elshafy et al., 2022[62]RV, HAV8WeeklyRT-qPCR1219.5% (RV); 14.3% (HAV)NRTunisiaHassine- Zaafrane et al., 2014[63]NoV37Once a weekRT-PCR225938.6%GIBéji-Hamza et al., 2014[64]HAV24MonthlyNested RT-PCR37968.3%IAHassine-Zaafrane et al., 2015[65]RVA37Once a weekRT-qPCR225976.1%G1 and P[8]BahrainJanahi et al., 2020[66]RV, HAV4‡NRRT-PCR116§12.5% (RV); 12.5% (HAV)NRJordanSaadoun et al., 2021[67]HAV, NoV11NRNested RT-PCR (HAV); RT-PCR (NoV)13NDNRAbbreviations: HAV Hepatitis A virus, NoV Norovirus, RV Rotavirus, RVA Rotavirus A, RVC Rotavirus C, RT-PCR Reverse-Transcriptase Polymerase Chain Reaction, WWTP Wastewater Treatment Plant, ND Not Detected, NR Not Reported, NA Not Available*Two separate sampling periods divided into 6 months each†Exact numbers for raw sewage included in our study was not reported.‡2 separate sampling periods divided into 2 months each§Refers to raw and treated sewage, no distinction for number of raw sewage samples only Wastewater surveillance data of rotavirus, norovirus and hepatitis A in the MENA region (2014-2024) Abbreviations: HAV Hepatitis A virus, NoV Norovirus, RV Rotavirus, RVA Rotavirus A, RVC Rotavirus C, RT-PCR Reverse-Transcriptase Polymerase Chain Reaction, WWTP Wastewater Treatment Plant, ND Not Detected, NR Not Reported, NA Not Available *Two separate sampling periods divided into 6 months each †Exact numbers for raw sewage included in our study was not reported. ‡2 separate sampling periods divided into 2 months each §Refers to raw and treated sewage, no distinction for number of raw sewage samples only Wastewater surveillance data of RV, NoV and HAV in the MENA region Reverse transcriptase polymerase chain reaction (RT-PCR), nested RT-PCR and RT-qPCR, were used for viral detection across the included studies (Table 2). RV was the most studied virus, with seven out of the 11 studies reporting its detection; these studies were conducted in Egypt (five studies), Tunisia (one study) and Bahrain (one study). A wide range of RV positivity rates in WW was reported (8.3%-100%). Studies from Egypt reported 16.7% and 50% RVA positivity rates across two studies, while those of RVC ranged from 8.3% to 21.9%. A higher RV detection rate was reported in the study originating from Tunisia (76.1%) compared to Bahrain (12.5%). Only 3 out of the seven studies reported on the distribution of the G and P types of RVA. G1 and P[8] were the predominantly detected genotypes in Tunisia and Egypt. Tunisia exhibited notable diversity with the detection of nine G types (G2-G6, G8-G11) and six P types (P[1], P 4]-P[7], P[9]) versus only two G-types (G3 and G9) and P[6] in Egypt. NoV was the least reported virus across studies. The positivity rate was 38.6% in one study originating from Tunisia, whereas it was not detected as reported by the study originating from Jordan. However, the latter is not representative due to the small sample size (n = 3). The identified genotypes in Tunisia included GI.5, GI.1, GI.4, GI.2, and GII.12, with the predominance of the GI genogroup. Five studies monitored HAV in WW, and were distributed as follows: Egypt (two studies), Tunisia (one study), Bahrain (one study) and Jordan (one study). The reported positivity rates among all studies were: none in Jordan, 12.5% in Bahrain, 68.3% in Tunisia, and 79.4% and 14.3% in Egypt. Genotypes IA and IB were reported in Tunisia with the predominance of the former. On the other hand, the only reported genotype in Egypt was IB upon investigating only a selected number of HAV positive samples. Three studies (27%) originating from Egypt and Tunisia, reported on seasonal trends, all of which focused on RV. RVA and RVC peaks were reported in Egypt during autumn and winter, whereas spring peaks were reported in Tunisia. A fourth study originating from Bahrain reported a lack of statistically significant seasonal variation. Risk of bias assessment The majority of the included studies (8 studies, 73%) were graded at a moderate risk of bias, with the remaining three studies as low risk of bias (Table S1). The moderate risk of bias was due to several factors, such as the lack of population representation linked to low number of WWTPs tested compared to the study population. Other factors including samples’ representation of the targeted environmental source, i.e., influent of WWTPs, mode of sample collection, and length of study period also contributed to the moderate risk classification. Discussion The significance of WWS for monitoring circulating trends of RV, NoV, and HAV, has been previously demonstrated; whereby these viruses were detected in WW prior to clinical detection [20–23]. Despite the global recognition of WWS as a cost-efficient early warning system for circulating pathogens like Poliovirus and SARS-CoV-2, and its proven efficacy in monitoring trends of anti-microbial resistance worldwide [1–5, 10–14, 68–72], there is lack of substantial information regarding its utilization as an epidemiological surveillance tool for viral diarrheal illnesses in the MENA region. To our knowledge, this is the first systematic review advancing a critical overview of the current applications of WWS for the detection of RV, NoV, and HAV in the MENA region. According to UNICEF, the MENA region has the world’s scarcest water resources, holding only 2% of renewable fresh water and hosting 6% of the global population [73]. This water crisis is further exacerbated by rapid population growth, urbanization, socioeconomic disparities, conflicts, displacement, and unsustainable water management [73, 74]. These factors result in sub-optimal living conditions for residents and displaced populations, many of whom lack access to safe and clean water [75]. Data from UNICEF reveals that 66 million people residing in the MENA region lack basic sanitation services [74], where 57% of the annual WW produced in the region is discharged to the environment untreated [76]. Importantly, only 36% of the population in low-middle income countries (LMICs) in the EMR have access to safely managed drinking water free from fecal contamination and priority chemical depositions [77]. Moreover, the administration of HAV vaccine in the MENA region is limited to eight out of 20 countries; whereby it is included on the National Immunization Program (NIP) list of Bahrain, Oman, Qatar, Saudi Arabia, and Tunisia, while Iraq, Kuwait, and the United Arab Emirates (UAE) restrict its use to high-risk groups (Iraq and UAE), healthcare personnel (Kuwait), citizens born prior to 1990 (Kuwait), and travelers (UAE) [36, 78, 79]. RV vaccination is on the NIP of 14 out of 20 countries of the region [80]. Data on the prevalence of RV, NoV, and HAV are lacking in the region [81–83]. A recent systematic review and meta-analysis covering Europe and the Middle East showed that Qatar was the only country reporting on the prevalence of RV genotypes in the vaccine post-licensure period and specifically between 2016 and 2021 [84]. Moreover, an epidemiologic shift of HAV burden in the EMR was highlighted in a recent study where LICs maintain high HAV immunity and are transitioning to low-endemicity, while MICs and HICs are experiencing increased susceptibility among adolescents, rendering the latter a niche for HAV infections and future outbreaks [78]. This review highlights the scarcity of data from the MENA region. Data were available from Egypt, Tunisia, Bahrain and Jordan, leaving the majority of MENA countries underrepresented, especially those affected by conflict and displacement [85]. The included studies performed sampling of untreated WW from WWTPs, which grants a high population coverage. Despite that, the advanced data were not integrated within national surveillance systems, and do not reflect the burden of RV, NoV or HAV. According to the World Bank classification, countries of the MENA region are classified as HIC, upper-middle income, LMIC, and LIC. However, the countries included in this review showcase WW data from only LMICs (Egypt, Tunisia and Jordan) and one HIC (Bahrain) [86], which does not mirror the diverse socioeconomic status of the MENA region. Recent systematic reviews reported a higher prevalence of RV (65%) and HAV (29%) in LICs, while HICs had a prevalence of 48.27% and 10.8%, respectively [40, 41]. The majority of countries of the MENA region are LICs and LMICs suffering from multiple concurrent crises leading to weak water infrastructure, fragile surveillance systems along with inequitable access to care; thus, increasing the risk of viral diarrheal illnesses and supporting the need to invest and transition into multipathogen WWS. A number of challenges exist and hinder the integration of WWS in under-resourced countries of the region; these include the lack of genomic infrastructure of national surveillance programs including physical (laboratory capacity) and human resources (skilled personnel), and the sustainability of routine and agile WWS programs [87]. Moreover, published WWS initiatives and national programs often focus on WW monitoring within centralized sewage systems; while a large proportion of the population in many countries of the MENA region is served by septic tanks, cesspits and small decentralized treatment plants [88]. Despite these challenges, WWS has been proven successful as an early warning system for several pathogens as well monitoring trends of antimicrobial resistance [1–5, 10–14, 68–72]. The cost effectiveness of WWS at determining the circulation of viruses at the population level including vulnerable groups with limited access to care, would predict dynamics of disease transmission prior to clinical surges and thus enhance advancement of timely public health interventions [87]. The majority of studies (73%) had a moderate risk of bias and only three had a low risk (27%). The former could be linked to the methodological quality of the studies and the validity and reliability of their respective findings. Variables such as the sampling frequency, collection methods, and sample size along with factors such as the lack of population representation, limited number of WWTPs tested, and inconsistent sampling methods could be potential sources of bias. The included studies did not offer information about seasonal trends of NoV or HAV, with inconsistent data on RV. Moreover, the available data on reported genotypes was restricted to Tunisia and Egypt, which are not representative of the MENA region ; thus, limiting our ability to suggest information on the genetic diversity of these viruses in the region. WWS complements clinical testing and offers insights into its timeliness and sensitivity at the community level, as demonstrated during the COVID-19 pandemic [4, 10–14, 23]. Previous data advanced the correlation between circulating RV, NoV and HAV in WW and clinical epidemiological data. A retrospective and longitudinal study in California testing the prevalence of RV and NoV in untreated WW from two WWTPs advanced a direct correlation between the detection of RV and NoV GII in one of the tested WWTPs for the former, and for both in the latter [43]. Similarly, data from a recent systematic review and meta-analysis on NoV revealed a significant positive correlation between the concentration of NoV GII in WW and each of GII Acute Gastroenteritis (AGE) cases, total AGE cases, and NoV outbreaks in Europe and Asia [39]. A three-year epidemiological study on the circulation of HAV in Argentina showed that the detection frequencies of HAV in WW coincided with peaks of clinically reported cases [42]. Moreover, the correlation of WWS and clinical data has been documented in the USA [89], and also in resource-limited countries such as Costa Rica [90]. These studies confirm the complementarity between WWS and clinical data, and the significance of WW for monitoring trends of diseases. In this review, only four studies originating from Tunisia and Egypt linked their WWresults to clinical data [57, 60, 63, 65], whereby genotypes of RV and NoV detected in stool samples collected from patients in the vicinity of the WWTPs were similar to those detected in WW. This review has several limitations. The included studies lacked standardized methodologies, did not report on seasonal variations, and originated from a small number of countries; thus, hindering our ability to draw conclusions on the circulation and molecular epidemiology of these viruses in the community along with their temporal dynamics. The sampling periods and sample size were highly variable preventing the generalizability of results - especially positivity rates - and may introduce a potential source of bias. The development of WWS programs for viral diarrheal illnesses is urgently needed in the MENA region to advance evidence-based community trends of circulating pathogens. It complements clinical surveillance, is less expensive and is not subject to bias due to disparity in access to care, and importantly is able to detect blind spots of circulating pathogens. These factors are extremely important in countries of the MENA region, especially those hosting refugees and are in conflict. Countries of the MENA should invest in establishing sustainable WWS national and regional programs linked to epidemiologic surveillance in order to guide public health strategies. Conclusion This review demonstrates the need to expand WWS in the MENA region to monitor RV, NoV, and HAV in order to better understand the epidemiology and burden caused by these understudied viruses. WWS plays a pivotal role in monitoring trends of viral circulation at the community level to mitigate the impact of viral gastroenteritis caused by RV, NoV and HAV, as well as guiding national public health interventions . It is important for countries of the region to prioritize the establishment and integration of WWS into existing disease surveillance systems to serve as an early warning system supporting rapid response measures. Supplementary Information Supplementary Material 1. Supplementary Material 1. Supplementary Material 2. Supplementary Material 2. Supplementary Material 3. Supplementary Material 3.